Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial
Hope S. Rugo*, Seock Ah Im, Fatima Cardoso, Javier Cortés, Giuseppe Curigliano, Antonino Musolino, Mark D. Pegram, Gail S. Wright, Cristina Saura, Santiago Escrivá-De-Romaní, Michelino De Laurentiis, Christelle Levy, Ursa Brown-Glaberman, Jean Marc Ferrero, Maaike De Boer, Sung Bae Kim, Katarína Petráková, Denise A. Yardley, Orit Freedman, Erik H. JakobsenBella Kaufman, Rinat Yerushalmi, Peter A. Fasching, Jeffrey L. Nordstrom, Ezio Bonvini, Scott Koenig, Sutton Edlich, Shengyan Hong, Edwin P. Rock, William J. Gradishar
Research output: Contribution to journal › Article › peer-review
247Scopus
citations
Fingerprint
Dive into the research topics of 'Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial'. Together they form a unique fingerprint.